» Articles » PMID: 36406057

Drug Therapy and Medication Adherence in Type 2 Diabetes in a Care Facility: A Cross Sectional Survey

Overview
Date 2022 Nov 21
PMID 36406057
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Adherence to medications improves glycaemic control and reduces diabetes-related morbidity and mortality.

Objectives: The study assessed drug therapy for type 2 diabetes, glycaemic control and association of medication adherence with socio-demographic and clinical data, among adult diabetic patients attending a healthcare facility.

Methods: Cross-sectional survey and hospital records were used to obtain data. The study included 200 adults with type 2 diabetes mellitus in a Nigerian healthcare facility. Data on patients clinical characteristics, diabetes drug therapy and medication adherence were collected, entered and anlaysed using SPSS version 24 . Primary outcome measure was medication adherence among the patients, while secondary outcome measures was glycaemic control.

Results: A total of 200 (100%) respondents participated in the study and the majority 141(70.5%) were over 60 years old. Oral medications were mostly used 187(93.5%), particularly, metformin 199(99.5%) and pioglitazone 100(50.0%), while dipeptidyl peptidase-4 inhibitors were not used at all. Patients mostly had poor glycaemic control 159 (79.5%) and majority 152(76.0%) did not practice self-blood glucose monitoring. Moderate medication adherence was predominant in the population. Class of medicine and socio-demographics were not significantly associated with medication adherence ), unlike results of blood glucose self-tests ( ).

Conclusion: Oral antidiabetics, particularly metformin and pioglitazone were mostly used. Poor glycaemic control and moderate adherence were found in the patients, and medication adherence was associated with self-glucose monitoring. This emphasises the need for regular diabetes education on medication adherence.

Citing Articles

Assessment of Medication Adherence in Diabetes Mellitus Patients at a Tertiary Care Teaching Hospital in India.

Shah S, Barot P, Patel H, Shukla A Cureus. 2025; 17(2):e78391.

PMID: 40046369 PMC: 11879787. DOI: 10.7759/cureus.78391.


Adverse Drug Reactions and Predictors of Medication Adherence in Patients with Prostate Cancer.

Iheanacho C, Odili V Can J Hosp Pharm. 2024; 77(4):e3567.

PMID: 39386970 PMC: 11426963. DOI: 10.4212/cjhp.3567.

References
1.
Iheanacho C, Osoba D, Eze U . Evaluation of predominant risk factors for type 2 diabetes mellitus among out-patients in two Nigerian secondary health facilities. Afr Health Sci. 2021; 21(2):693-701. PMC: 8568255. DOI: 10.4314/ahs.v21i2.27. View

2.
Aminde L, Tindong M, Ngwasiri C, Aminde J, Njim T, Fondong A . Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon. BMC Endocr Disord. 2019; 19(1):35. PMC: 6446302. DOI: 10.1186/s12902-019-0360-9. View

3.
Rezaei M, Valiee S, Tahan M, Ebtekar F, Gheshlagh R . Barriers of medication adherence in patients with type-2 diabetes: a pilot qualitative study. Diabetes Metab Syndr Obes. 2019; 12:589-599. PMC: 6507070. DOI: 10.2147/DMSO.S197159. View

4.
. Standards of medical care in diabetes--2007. Diabetes Care. 2006; 30 Suppl 1:S4-S41. DOI: 10.2337/dc07-S004. View

5.
Inzucchi S, Bergenstal R, Buse J, Diamant M, Ferrannini E, Nauck M . Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2014; 38(1):140-9. DOI: 10.2337/dc14-2441. View